<DOC>
	<DOC>NCT00527085</DOC>
	<brief_summary>4 doses of AMG 073 or placebo over 52 weeks after a 30-day screening period. Throughout the study, labs will be drawn to measure analytes such as iPTH and corrected calcium. In addition, a bone biopsy will be performed at screening and at the end of study.</brief_summary>
	<brief_title>12-month Study of AMG 073 in Renal Osteodystrophy</brief_title>
	<detailed_description />
	<mesh_term>Renal Osteodystrophy</mesh_term>
	<mesh_term>Cinacalcet Hydrochloride</mesh_term>
	<criteria>18 years of age of greater Using effective contraceptive measures iPTH greater than or equal to 300 pg/mL Serum Calcium greater than or equal to 8.4 mg/dL; Hemoglobin greater than 9 Stable hemodialysis for 1 month prior to day 1 Any unstable medical condition Pregnant or nursing women Recent parathyroidectomy Change in Vitamin D therapy Recent MI, Seizure, Malignancy, GI Disorder Inability to swallow tablets</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
</DOC>